ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Nominations for the Broermann Medical Innovation Award 2026 now open

By: PR Leap
(PRLeap.com) • With a million euros, it is one of the world's most highly endowed awards for medical research

Hamburg, 4. September 2025. The nomination period for the Broermann Medical Innovation Award 2026 has begun. Endowed with a million euros, this international award is among the most prestigious honors for medical research worldwide. Scientists from around the globe who have made pioneering contributions in medicine, biotechnology, or related fields may be nominated. The nomination portal will remain open until March 1, 2026.

The Broermann Medical Innovation Award recognizes scientific breakthroughs with high innovation potential for clinical application. The focus is on research results that have a long-lasting impact on the lives and health of millions of people worldwide. The announcement of the award recipient and the second official Broermann Medical Innovation Award ceremony will take place in autumn 2026.

Debut of the Broermann Medical Innovation Award This Year
The award will be presented for the first time this year. The jury will announce the inaugural recipient of the Broermann Medical Innovation Award on September 18, 2025. The official award ceremony, hosted by the Minister-President of Hesse, Boris Rhein, will take place on November 14, 2025, at the Hessian State Chancellery in Wiesbaden.

About the Award
The Broermann Medical Innovation Award was established in 2024 to honor the vision and commitment of Dr. Bernard große Broermann, founder of the Asklepios Kliniken Group. The award is endowed by Broermann gemeinnützige GmbH and organized through the University Hospital Gießen and Marburg (UKGM). The award is intended to recognize groundbreaking medical discoveries and highlight those whose research is making real progress in the prevention or treatment of disease. The aim is to reflect the award founder's firm conviction that, although scientific excellence in medicine is always an international team effort, the impact of networks is limited without the genius of individual researchers. The Broermann Medical Innovation Award is intended to recognize and support these key figures and drivers of medical innovation worldwide.

Further information about the award, nomination criteria, and selection process can be found on the award website.


Contact:

Broermann Medical Innovation Award
Contact: Mirjam Malko
Tel.: +49 (0) 641 / 985-42310
E-Mail: contact@broermann-award.org

Asklepios Kliniken
Konzernbereich Unternehmenskommunikation & Marketing
Tel.: +49 (0) 40 / 18 18-82 66 36
E-Mail: presse@asklepios.com
24-hour press office hotline:+49 (0) 40 / 1818-82 8888

Visit Asklepios on the Internet and Social Media:
www.asklepios.com
www.asklepios.com/gesundheitsmagazin
http://www.youtube.com/asklepioskliniken
de.linkedin.com/company/asklepios
www.instagram.com/asklepioskliniken/
www.facebook.com/asklepioskliniken

GET IN TOUCH
Mirjam Malko
Asklepios Kliniken GmbH & Co. KGaA

https://www.asklepios.com/

You can see the original version and more on PRLeap here: http://www.prleap.com/pr/306761/nominations-for-the-broermann-medical-innovation-award-2026-now-open

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.